BRIEF-Idorsia Initiates Precision - Phase 3 Study With Aprocitentan
1 Min Read
June 20 (Reuters) - Idorsia Ltd:
* IDORSIA INITIATES PRECISION - PHASE 3 STUDY WITH APROCITENTAN FOR RESISTANT HYPERTENSION MANAGEMENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)